(PinkSheets:FLYYQ), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Spirit Aviation Holdings, Inc. (“Spirit” or “the Company”) (OTCMKTS: FLYYQ) and certain of its officers. Class Definition This lawsuit seeks to recover […]

EDEN PRAIRIE, Minn., Nov. 04, 2025 (GLOBE NEWSWIRE) — Arctic Wolf(R), a global leader in security operations, today announced plans to enhance Aurora(TM) Endpoint Security with upcoming AI-powered ransomware prevention and rollback capabilities. Through the acquisition of UpSight Security, Arctic Wolf will accelerate the development and future delivery of these features, expanding its ability to

(NASDAQ:FOXF), DULUTH, Ga., Nov. 04, 2025 (GLOBE NEWSWIRE) — FOX continues to push the potential of suspension technology with the introduction of Live Valve as an aftermarket upgrade for trucks and Jeeps. Live Valve is the most advanced semi active suspension system available for trucks and Jeeps. It senses terrain and driver inputs hundreds of times

(NASDAQ:OMDA), SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada's behavior change program on members currently or previously on GLP-1 medications for weight loss. Together, these analyses suggest that engagement with Omada

(NASDAQ:AARD), New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its opportunity in addressing key challenges in today's obesity treatment landscape Preclinical and clinical data demonstrates the potential of ARD-201 to attenuate weight gain, promote weight loss and help maintain weight after the discontinuation of

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Today, Chainlink and Validation Cloud announced a collaboration between Mavrik, Validation Cloud's domain-specific AI engine, and Chainlink's Cross-Chain Interoperability Protocol (CCIP). The collaboration seeks to connect artificial intelligence and cross-chain connectivity to redefine how institutions understand, navigate, and move digital assets across networks. The collaboration targets the

– Mean weight loss of 19.2%I at 6 mg with no plateau and favorable safety profile in 48-week Phase 3 clinical trial – – Data builds on previously reported Phase 2 results that showed mean weight loss of 23.6%I at 8 mg at week 36 with no plateau – – NDA submitted in China by

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Questex, a leading authority in the healthcare and life sciences sector, today announces the acquisitions of The Conference Forum and Versalinx Global Events. The life sciences industry is booming with $88.2 billion in sales (2024) and is expected to grow to $269.56 billion by 2034, at a

CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating obesity and associated cardiometabolic diseases, today announced that a poster of the first data from the company's preclinical pipeline of oral Controlled Metabolic Accelerators (CMAs) will be presented at ObesityWeek(R) organized by

(NASDAQ:SNPS), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for